Drug-resistant malignant tumor cells highly express very late antigen4 (VLA4), which enables malignant tumor cells to attach to MSCs via VCAM1, thereby activating the NK-κB signaling pathway (74). The gene discussed is VCAM1; the disease is neoplasm.